Related Experiment Video
Updated: Apr 28, 2026

Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study
Published on: March 31, 2022
Amphotericin B transfer to CSF following intravenous administration of liposomal amphotericin B
Volker Strenger1, Andreas Meinitzer2, Josef Donnerer3
1Department of Paediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria volker.strenger@medunigraz.at.
Objectives:
Although amphotericin B (AmB) and its lipid formulations are used for the treatment of fungal infections of the CNS, the kinetics of AmB in the CSF after intravenous administration of liposomal amphotericin B (LAmB) are not well characterized.
Patients And Methods:
From 14 paediatric haemato-oncological patients (aged 0.4-19.5 years, median 7.6 years), we obtained 30 CSF samples by means of routine punctures (performed for intrathecal treatment of the underlying diseases) at different timepoints after the prophylactic intravenous infusion of LAmB (AmBisome, 3 mg/kg/day). Concurrent serum samples were obtained to calculate the transfer rates. An HPLC method was used for AmB detection.
Results:
CSF levels of AmB 1-100 h after the intravenous infusion of LAmB were between 10 and 120 ng/mL, except in one case with a level of 529 ng/mL. Concurrent serum levels were about 1000-fold higher, ranging between 3 and 75 μg/mL. CSF levels did not show a clear time-dependent concentration profile, but remained at a steady-state for longer than 48 h after infusion. The transfer rate ranged from 0.02% to 0.92% (median 0.13%) and correlated significantly (r=0.801, P<0.001) with increasing time after infusion.
Conclusions:
After the intravenous administration of LAmB, AmB CSF levels were low, confirming published animal data. CSF levels remained at a steady-state level for longer than 48 h. As indicated by published post mortem data, higher levels in brain tissue, which would be necessary for the successful treatment of CNS infections, might be possible.
Insights
Liposomal amphotericin B (LAmB) administered intravenously results in low but sustained cerebrospinal fluid (CSF) levels of amphotericin B (AmB) in pediatric patients. These levels remain steady for over 48 hours, potentially allowing for effective treatment of CNS fungal infections.
Area of Science:
- Pharmacokinetics
- Neuroscience
- Infectious Diseases
Background:
- Amphotericin B (AmB) and its lipid formulations are crucial for treating central nervous system (CNS) fungal infections.
- The cerebrospinal fluid (CSF) pharmacokinetics of liposomal amphotericin B (LAmB) after intravenous administration are not well understood.
Purpose of the Study:
- To characterize the CSF kinetics of AmB following intravenous LAmB administration in pediatric patients.
- To determine AmB concentrations in CSF and serum and calculate transfer rates.
Main Methods:
- CSF and serum samples were collected from 14 pediatric patients receiving prophylactic intravenous LAmB (3 mg/kg/day).
- Samples were analyzed for AmB using High-Performance Liquid Chromatography (HPLC).
- 30 CSF samples were obtained at various time points post-infusion.
Main Results:
- CSF AmB levels ranged from 10-120 ng/mL, with one outlier at 529 ng/mL, 1-100 hours post-infusion.
- Serum levels were approximately 1000-fold higher than CSF levels.
- CSF levels exhibited a steady-state for over 48 hours, with a transfer rate of 0.02%-0.92% from serum.
Conclusions:
- Intravenous LAmB yields low but sustained AmB concentrations in CSF.
- The steady-state CSF levels persist beyond 48 hours.
- Higher brain tissue concentrations may be achievable, suggesting potential efficacy for CNS fungal infections.
Related Concept Videos
Antifungal Agents
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Cerebrospinal Fluid
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
Cerebral Edema ll: Pathophysiology
Cerebral Edema l: Introduction

